Lifecore Biomedical Inc (LFCR)
NASDAQ
Fin d'année 26 Mai 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | 3.017 | 6.506 | 0.089 | -7.203 | -6.256 | -24.416 | -36.29 | 4.734 |
Return on Equity (%) | 4.808 | 10.33 | 0.157 | -15.24 | -15.059 | -62.711 | -191.993 | 339.111 |
Return on Invested Capital (%) | 7.239 | 7.394 | 3.348 | -4.933 | -3.041 | -4.306 | -12.12 | -5.224 |
Operating Margin (%) | 3.164 | 3.5 | 1.591 | -7.064 | -4.617 | -18.709 | -44.814 | 21.522 |
Net Profit Margin (%) | 1.99 | 4.736 | 0.074 | -6.469 | -6.003 | -52.443 | -96.411 | 9.366 |
Book Value Per Share | 5.412 | 6.288 | 5.035 | 4.182 | 3.28 | 2.632 | 0.555 | 1.16 |
Earnings Per Share | 0.381 | 0.886 | 0.014 | -1.293 | -1.102 | -3.266 | -3.249 | 0.389 |
Cash Per Share | 0.194 | 0.103 | 0.037 | 0.012 | 0.044 | 0.055 | 0.623 | 0.274 |
Working Capital Per Share | 1.072 | 0.31 | -0.138 | -0.246 | 1.566 | 1.491 | 1.781 | 1.366 |
Operating Profit Per Share | 3.367 | 3.223 | 3.271 | 3.176 | 3.417 | 2.064 | 1.377 | 1.631 |
EBIT Per Share | 0.54 | 0.585 | 0.124 | -1.737 | -1.365 | -1.747 | -2.086 | 0.308 |
EBITDA Per Share | 0.54 | 0.585 | 0.124 | -1.737 | -1.365 | -1.747 | -2.086 | 0.308 |
Free Cash Flow Per Share | 0.816 | 1.658 | 1.017 | -1.027 | -0.97 | -2.698 | -2.901 | 0.694 |
Fin d'année 26 Mai 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 27,5M | 27,7M | 29,1M | 29,22M | 29,33M | 29,51M | N/A | N/A |
Fin d'année 26 Mai 2024 | Nov 2022 | Fév 2023 | Mai 2023 | Août 2023 | Nov 2023 | Fév 2024 | Mai 2024 | Août 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 30,3M | N/A | N/A | 30,46M | 30,46M | 30,55M | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | -35.005 | N/A | N/A | N/A | -44.068 |
Net Profit Margin (%) | N/A | N/A | N/A | -43.854 | N/A | N/A | N/A | -65.695 |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 214,43M |
Ratio cours/bénéfice | 18,18 |
Ratio prix/ventes | 1,7 |
Ratio prix/liquidités | 25,81 |
Ratio prix/valeur comptable | 4,05 |
Rendement de dividende | - |
Actions en circulation | 30,9M |
Volume moyen (1 semaine) | 169,64k |
Volume moyen (1 mois) | 190,2k |
Variation sur 52 semaines | 17,64% |
Plus haut sur 52 semaines | 8,90 |
Plus bas sur 52 semaines | 3,6793 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales